University of Nevada, Reno, Department of Microbiology and Immunology, Reno, Nevada, USA.
Biol Blood Marrow Transplant. 2011 Dec;17(12):1754-64. doi: 10.1016/j.bbmt.2011.08.023. Epub 2011 Sep 8.
Immune deficiency immediately following bone marrow transplantation (BMT) increases susceptibility to opportunistic infections as well as tumor relapse. Natural Killer (NK) cells play important roles in the resistance to virally infected and transformed cells. Interleukin (IL)-15 has been shown to be essential for NK cell development and survival. We administered human (h) IL-15 cDNA (pIL-15) via hydrodynamic delivery to murine recipients undergoing congenic BMT to determine its effects on NK cell reconstitution. Hydrodynamic pIL-15 delivery resulted in high levels of hIL-15 protein in the serum that lasted for several days and then quickly declined. The appearance of hIL-15 was followed by a significant increase of mature donor-derived NK cells within the bone marrow, spleens, and livers of the treated recipients. No accumulation of immature NK cell progenitors was observed. The NK cells from IL-15-treated recipients displayed an activated phenotype and were lytically active toward tumor targets in vitro to a similar degree as did those cells from recipients treated with control plasmid. This suggests that the predominant effect of IL-15 was a quantitative increase in total NK cell numbers and not qualitative changes in NK cell functions. No toxicities or adverse effects were observed. Studies performed in transplanted mice bearing renal carcinoma tumors demonstrated that this mode of hIL-15 gene delivery resulted in increased antitumor responses. These results support the use of cytokine gene transfer-based regimens as a platform to augment NK cell recovery after BMT.
骨髓移植(BMT)后立即出现的免疫缺陷会增加机会性感染和肿瘤复发的易感性。自然杀伤(NK)细胞在抵抗病毒感染和转化细胞方面发挥着重要作用。白细胞介素(IL)-15 已被证明对 NK 细胞的发育和存活至关重要。我们通过流体动力学传递向接受同基因 BMT 的小鼠受者给予人(h)IL-15 cDNA(pIL-15),以确定其对 NK 细胞重建的影响。流体动力学 pIL-15 传递导致血清中 hIL-15 蛋白水平升高,持续数天,然后迅速下降。hIL-15 的出现伴随着处理受者的骨髓、脾脏和肝脏中成熟供体衍生 NK 细胞的显著增加。未观察到不成熟 NK 细胞祖细胞的积累。来自 IL-15 处理受者的 NK 细胞表现出激活表型,并对体外肿瘤靶标具有溶细胞活性,与接受对照质粒处理的受者的 NK 细胞相似。这表明 IL-15 的主要作用是 NK 细胞总数的定量增加,而不是 NK 细胞功能的定性变化。未观察到毒性或不良反应。在患有肾细胞癌肿瘤的移植小鼠中进行的研究表明,这种 hIL-15 基因传递方式导致抗肿瘤反应增加。这些结果支持使用细胞因子基因转移为平台,在 BMT 后增强 NK 细胞的恢复。